Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964431 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Study of Indomethacin Capsules to Treat Dental Pain
A Phase 2 study, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 203
- Enrollment target
NCT00964431 is a Phase 2 study that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 203 participants.
The verdict
NCT00964431, a Phase 2 study, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 203 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
Interventions
- DRUG Placebo
- DRUG Celecoxib 400 mg
- DRUG Indomethacin Test (lower dose)
- DRUG Indomethacin Test (upper dose)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964431
The ClinicalTrials.gov registry entry for NCT00964431 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00964431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964431 about?
NCT00964431 is a clinical study titled "Phase 2 Study of Indomethacin Capsules to Treat Dental Pain". The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
What is the current status of trial NCT00964431?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 203 participants. The study started on 2009-08. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00964431?
The interventions under investigation include: Placebo (DRUG), Celecoxib 400 mg (DRUG), Indomethacin Test (lower dose) (DRUG), Indomethacin Test (upper dose) (DRUG).
Who is sponsoring clinical trial NCT00964431?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.